Anders Kindberg Boysen1,2, Jakob Vasehus Schou3, Karen-Lise Garm Spindler4,5. 1. Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark. andboy@rm.dk. 2. Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark. andboy@rm.dk. 3. Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Hellerup, Denmark. 4. Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark. 5. Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark.
Abstract
BACKGROUND: Preoperative chemoradiotherapy is the standard of care for patients with locally advanced rectal cancer, yet valid circulating biomarkers are lacking. We aimed at systematically reviewing the literature of cell-free DNA and locally advanced rectal cancer. METHODS: A systematic literature search was performed. We retrieved papers reporting a correlation between a clinical outcome and cell-free DNA for patients receiving chemoradiotherapy for locally advanced rectal cancer. RESULTS: We included nine studies of a total of 615 patients. Only single-arm studies were identified, analyzing either the total level of cell-free DNA or tumor-specific DNA. Despite differences in the methodology and outcomes, eight of the nine studies showed a correlation between cell-free DNA and a clinical outcome. CONCLUSIONS: Cell-free DNA might hold prognostic and predictive information for patients with locally advanced rectal cancer receiving preoperative chemoradiotherapy; although, firm conclusions are limited by the heterogeneity in this field.
BACKGROUND: Preoperative chemoradiotherapy is the standard of care for patients with locally advanced rectal cancer, yet valid circulating biomarkers are lacking. We aimed at systematically reviewing the literature of cell-free DNA and locally advanced rectal cancer. METHODS: A systematic literature search was performed. We retrieved papers reporting a correlation between a clinical outcome and cell-free DNA for patients receiving chemoradiotherapy for locally advanced rectal cancer. RESULTS: We included nine studies of a total of 615 patients. Only single-arm studies were identified, analyzing either the total level of cell-free DNA or tumor-specific DNA. Despite differences in the methodology and outcomes, eight of the nine studies showed a correlation between cell-free DNA and a clinical outcome. CONCLUSIONS: Cell-free DNA might hold prognostic and predictive information for patients with locally advanced rectal cancer receiving preoperative chemoradiotherapy; although, firm conclusions are limited by the heterogeneity in this field.
Authors: E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245
Authors: Marco Agostini; Salvatore Pucciarelli; Maria Vittoria Enzo; Paola Del Bianco; Marta Briarava; Chiara Bedin; Isacco Maretto; Maria Luisa Friso; Sara Lonardi; Claudia Mescoli; Paola Toppan; Emanuele Urso; Donato Nitti Journal: Ann Surg Oncol Date: 2011-03-17 Impact factor: 5.344
Authors: Gina Brown; Catherine J Richards; Michael W Bourne; Robert G Newcombe; Andrew G Radcliffe; Nicholas S Dallimore; Geraint T Williams Journal: Radiology Date: 2003-05 Impact factor: 11.105
Authors: Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt Journal: Ann Intern Med Date: 2011-10-18 Impact factor: 25.391
Authors: Isrid Sturm; Beate Rau; Peter M Schlag; Peter Wust; Bert Hildebrandt; Hanno Riess; Steffen Hauptmann; Bernd Dörken; Peter T Daniel Journal: BMC Cancer Date: 2006-05-10 Impact factor: 4.430
Authors: F V Negri; N Campanini; R Camisa; F Pucci; S Bui; G Ceccon; R Martinelli; M Fumagalli; P L Losardo; P Crafa; C Bordi; S Cascinu; A Ardizzoni Journal: Br J Cancer Date: 2007-12-18 Impact factor: 7.640
Authors: Matthias Zitt; Hannes M Müller; Marina Rochel; Verena Schwendinger; Marion Zitt; Georg Goebel; Alexander Devries; Raimund Margreiter; Michael Oberwalder; Robert Zeillinger; Dietmar Ofner Journal: Dis Markers Date: 2008 Impact factor: 3.434
Authors: Arvind Dasari; Van K Morris; Carmen J Allegra; Chloe Atreya; Al B Benson; Patrick Boland; Ki Chung; Mehmet S Copur; Ryan B Corcoran; Dustin A Deming; Andrea Dwyer; Maximilian Diehn; Cathy Eng; Thomas J George; Marc J Gollub; Rachel A Goodwin; Stanley R Hamilton; Jaclyn F Hechtman; Howard Hochster; Theodore S Hong; Federico Innocenti; Atif Iqbal; Samuel A Jacobs; Hagen F Kennecke; James J Lee; Christopher H Lieu; Heinz-Josef Lenz; O Wolf Lindwasser; Clara Montagut; Bruno Odisio; Fang-Shu Ou; Laura Porter; Kanwal Raghav; Deborah Schrag; Aaron J Scott; Qian Shi; John H Strickler; Alan Venook; Rona Yaeger; Greg Yothers; Y Nancy You; Jason A Zell; Scott Kopetz Journal: Nat Rev Clin Oncol Date: 2020-07-06 Impact factor: 65.011